Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$150M |
| 2 |
ExxonMobil
XOM
|
+$121M |
| 3 |
Visa
V
|
+$94.9M |
| 4 |
Columbia Banking Systems
COLB
|
+$94.4M |
| 5 |
GE HealthCare
GEHC
|
+$89.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$320M |
| 2 |
JPMorgan Chase
JPM
|
+$209M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$96.7M |
| 4 |
GE Aerospace
GE
|
+$89M |
| 5 |
ConocoPhillips
COP
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.26% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
3326
Crescent Biopharma
CBIO
$555M
| $84.1K | ﹤0.01% |
668
-75
| -10% | -$16.9K |
|
|
RVLP
3327
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $82.9K | ﹤0.01% |
72,664
-23,487
| -24% | -$28.2K |
|
3328
Absci
ABSI
$1.29B
| $82K | ﹤0.01% |
46,840
| – | – |
|
3329
Flux Power
FLUX
$11.5M
| $81.2K | ﹤0.01% |
16,718
| – | – |
|
3330
Sonida Senior Living
SNDA
$1.9B
| $81.1K | ﹤0.01% |
11,941
-8,218
| -41% | -$103K |
|
|
WPRT
3331
Westport Fuel Systems
WPRT
$32.7M
| $81.1K | ﹤0.01% |
8,527
-95
| -1% | -$973 |
|
|
SYRS
3332
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $80.7K | ﹤0.01% |
30,226
| – | – |
|
|
NEWP
3333
New Pacific Metals
NEWP
$881M
| $80.2K | ﹤0.01% |
29,802
-2,860
| -9% | -$7.3K |
|
3334
Outdoor Holding Co
POWW
$247M
| $79.9K | ﹤0.01% |
40,546
-76,285
| -65% | -$158K |
|
|
HYFT
3335
MindWalk Holdings
HYFT
$63.4M
| $79.4K | ﹤0.01% |
28,652
+991
| +4% | +$4.11K |
|
3336
FuboTV Inc
FUBO
$253M
| $79.3K | ﹤0.01% |
5,499
-6
| -0.1% | -$137 |
|
|
LGO
3337
Largo
LGO
$59.4M
| $79.3K | ﹤0.01% |
15,301
| – | – |
|
3338
Altisource Portfolio Solutions
ASPS
$58.8M
| $78.5K | ﹤0.01% |
2,133
-394
| -16% | -$19K |
|
|
CELL
3339
DELISTED
PhenomeX Inc. Common Stock
CELL
| $78.4K | ﹤0.01% |
67,611
-8,143
| -11% | -$14.9K |
|
3340
Virgin Galactic
SPCE
$329M
| $77.4K | ﹤0.01% |
955
+359
| +60% | +$35.8K |
|
3341
Immunome
IMNM
$2.61B
| $77K | ﹤0.01% |
+15,433
| New | +$75.5K |
|
3342
Lightpath Technologies
LPTH
$648M
| $76.9K | ﹤0.01% |
54,543
-34,320
| -39% | -$53.3K |
|
3343
WidePoint Corp
WYY
$97M
| $76.5K | ﹤0.01% |
42,264
-1,219
| -3% | -$2.45K |
|
3344
Precigen
PGEN
$2.12B
| $76.3K | ﹤0.01% |
72,160
-34,940
| -33% | -$50.4K |
|
3345
Sera Prognostics
SERA
$82.2M
| $76.3K | ﹤0.01% |
+19,921
| New | +$52.3K |
|
3346
CEL-SCI Corp
CVM
$21.3M
| $75.1K | ﹤0.01% |
1,080
-193
| -15% | -$15.1K |
|
3347
Cartesian Therapeutics
RNAC
$227M
| $74.9K | ﹤0.01% |
1,795
| – | – |
|
3348
Nautilus Biotechnolgy
NAUT
$131M
| $74.4K | ﹤0.01% |
+26,870
| New | +$56.4K |
|
3349
Sono-Tek
SOTK
$80.6M
| $74.4K | ﹤0.01% |
14,534
-2,191
| -13% | -$12.5K |
|
3350
Oxbridge Re Holdings
OXBR
$10.6M
| $73.2K | ﹤0.01% |
41,369
-13,384
| -24% | -$27.3K |
|
Similar funds
Dimensional Fund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Dimensional Fund Advisors held 3,570 positions worth $297B, up 87,611% from $338M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2023 filing shows 79 new, 2,112 increased, 1,113 reduced and 109 closed positions. Its largest new stake was GE HealthCare: 1,253,762 shares worth $103M. The largest sale was Walmart Inc, an estimated $320M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2023 buy was GE HealthCare: 1,253,762 shares worth $103M.
- Dimensional Fund Advisors added most to Apple in Q1 2023, an estimated $150M increase.
- Dimensional Fund Advisors's biggest Q1 2023 reduction was Walmart Inc, cutting an estimated $320M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Sustainability Core 1 ETF in Q1 2023, selling an estimated $11.3M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $297B portfolio in Q1 2023.
- Dimensional Fund Advisors opened 79 new positions and closed 109 in Q1 2023.
- Dimensional Fund Advisors's portfolio value rose 87,611% quarter-over-quarter to $297B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.